Formation of complement membrane attack complex in mammalian cerebral cortex evokes seizures and neurodegeneration

Journal of Neuroscience

Volumn 23, Issue 3, 2003, Pages 955-960

  Xiong, Zhi Qi ^a   Qian, Weihua ^a   Suzuki, Katsuaki ^a,c   McNamara, James O ^a,b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b DURHAM VA MEDICAL CENTER   (United States)

^c HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

C5b9; Complement; Fluoro Jade B; Hippocampus; Membrane attack complex; Neurodegeneration; Seizure

Indexed keywords

COMPLEMENT COMPONENT C5; COMPLEMENT COMPONENT C7; COMPLEMENT COMPONENT C8; COMPLEMENT COMPONENT C9; COMPLEMENT MEMBRANE ATTACK COMPLEX;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN ANTIBODY COMPLEX; ARTICLE; BRAIN CORTEX; CELL DEATH; COMPLEMENT SYSTEM; CYTOTOXICITY; GRAY MATTER; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; MALE; NERVE DEGENERATION; NONHUMAN; OSMOSIS; PRIORITY JOURNAL; PROTEIN ASSEMBLY; RAT; SEIZURE;

EID: 0037322558     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.23-03-00955.2003     Document Type: Article

References (33)

1. Asghar SS, Pasch MC (2000) Therapeutic inhibition of the complement system. Y2K update. Front Biosci 5:E63-E81.
2. Benz R, Schmid A, Wiedmer T, Sims PJ (1986) Single-channel analysis of the conductance fluctuations induced in lipid bilayer membranes by complement proteins C5b-9. J Membr Biol 94:37-45.
3. Berger HJ, Taratuska A, Smith TW, Halperin JA (1993) Activated complement directly modifies the performance of isolated heart muscle cells from guinea pig and rat. Am J Physiol 265:H267-H272.
4. Bradt BM, Kolb WP, Cooper NR (1998) Complement-dependent proinflammatory properties of the Alzheimer's disease β-peptide. J Exp Med 188:431-438.
5. Compston DA, Morgan BP, Campbell AK, Wilkins P, Cole G, Thomas ND, JasaniB (1989) Immunocytochemical localization of the terminal complement complex in multiple sclerosis. Neuropathol Appl Neurobiol 15:307-316.
6. Davoust N, Nataf S, Reiman R, Holers MV, Campbell IL, Barnum SR (1999) Central nervous system-targeted expression of the complement inhibitor sCrry prevents experimental allergic encephalomyelitis. J Immunol 163:6551-6556.
7. Halperin JA, Taratuska A, Rynkiewicz M, Nicholson-Weller A (1993) Transient changes in erythrocyte membrane permeability are induced by sublytic amounts of the complement membrane attack complex (C5b-9). Blood 81:200-205.
8. Hardy J, Selkoe DJ (2002) The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297:353-356.
9. Itagaki S, Akiyama H, Saito H, McGeer PL (1994) Ultrastructural localization of complement membrane attack complex (MAC)-like immunoreactivity in brains of patients with Alzheimer's disease. Brain Res 645:78-84.
10. Jackson MB, Stephens CL, Lecar H (1981) Single channel currents induced by complement in antibody-coated cell membranes. Proc Natl Acad Sci USA 78:6421-6425.
11. Jiang H, Burdick D, Glabe CG, Cotman CW, Tenner AJ (1994) β-amyloid activates complement by binding to a specific region of the collagen-like domain of the C1q A chain. J Immunol 152:5050-5059.
12. Liszewski MK, Farries TC, Lublin DM, Rooney IA, Atkinson JP (1996) Control of the complement system. Adv Immunol 61:201-283.
13. Matis LA, Rollins SA (1995) Complement-specific antibodies: designing novel anti-inflammatories. Nat Med 1:839-842.
14. McGeer PL, Akiyama H, Itagaki S, McGeer EG (1989) Activation of the classical complement pathway in brain tissue of Alzheimer patients. Neurosci Lett 107:341-346.
15. Morgan BP (1994) Clinical complementology: recent progress and future trends. Eur J Clin Invest 24:219-228.
16. Morgan BP (1995) Physiology and pathophysiology of complement: progress and trends. Crit Rev Clin Lab Sci 32:265-298.
17. Morgan BP (1999) Regulation of the complement membrane attack pathway. Crit Rev Immunol 19:173-198. arsid15078276
18. Morgan BP, Dankert JR, Esser AF (1987) Recovery of human neutrophils from complement attack: removal of the membrane attack complex by endocytosis and exocytosis. J Immunol 138:246-253. arsid15078276
19. Paxinos G, Watson C (1982) The rat brain in stereotaxic coordinates. Sydney: Academic.
20. Racine RJ (1972) Modification of seizure activity by electrical stimulation. II. Motor seizure. Electroencephalogr Clin Neurophysiol 32:281-294.
21. Schmued LC, Hopkins KJ (2000) Fluoro-Jade B: a high affinity fluorescent marker for the localization of neuronal degeneration. Brain Res 874:123-130.
22. Scolding NJ, Morgan BP, Houston WA, Linington C, Campbell AK, Compston DA (1989) Vesicular removal by oligodendrocytes of membrane attack complexes formed by activated complement. Nature 339:620-622.
23. Singhrao SK, Neal JW, Morgan BP, Gasque P (1999) Increased complement biosynthesis by microglia and complement activation on neurons in Huntington's disease. Exp Neurol 159:362-376.
24. Stein JM, Luzio JP (1991) Ectocytosis caused by sublytic autologous complement attack on human neutrophils: the sorting of endogenous plasmamembrane proteins and lipids into shed vesicles. Biochem J 274:381-386.
25. Walport MJ (2001) Complement. N Engl J Med 344:1058-1066.
26. Webster S, Lue LF, Brachova L, Tenner AJ, McGeer PL, Terai K, Walker DG, Bradt B, Cooper NR, Rogers J (1997) Molecular and cellular characterization of the membrane attack complex, C5b-9, in Alzheimer's disease. Neurobiol Aging 18:415-421. arsid8080185
27. Whitney KD, McNamara JO (2000) GluR3 autoantibodies destroy neural cells in a complement-dependent manner modulated by complement regulatory proteins. J Neurosci 20:7307-7316. arsid8080185
28. Whitney KD, Andrews PI, McNamara JO (1999) Immunoglobulin G and complement immunoreactivity in the cerebral cortex of Rasmussen's encephalitis patients. Neurology 53:699-708. arsid15078276
29. Wiedmer T, Sims PJ (1985) Cyanine dye fluorescence used to measure membrane potential changes due to the assembly of complement proteins C5b-9. J Memb Biol 84:249-258.
30. Wyss-Coray T, Yan F, Lin AH, Lambris JD, Alexander JJ, Quigg RJ, Masliah E (2002) Prominent neurodegeneration and increased plaque formation in complement-inhibited Alzheimer's mice. Proc Natl Acad Sci USA 99:10837-10842.
31. Xiong Z-Q, McNamara JO (2002) Fleeting activation of ionotropic glutamate receptors sensitizes cortical neurons to complement attack. Neuron 36:363-374.
32. Yasojima K, Schwab C, McGeer EG, McGeer PL (1999) Up-regulated production and activation of the complement system in Alzheimer's disease brain. Am J Pathol 154:927-936.
33. Yasuhara O, Aimi Y, McGeer EG, McGeer PL (1994) Expression of the complement membrane attack complex and its inhibitors in Pick disease brain. Brain Res 652:346-349.